Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesis.

Source:http://linkedlifedata.com/resource/pubmed/id/16610783

J. Med. Chem. 2006 Apr 20 49 8 2398-406

Download in:

View as

Triples

General Info

PMID
16610783